SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028972
Filing Date
2022-08-10
Accepted
2022-08-10 17:15:49
Documents
45
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20220630.htm   iXBRL 10-Q 1958312
2 EX-31.1 tcon-ex311_7.htm EX-31.1 9364
3 EX-31.2 tcon-ex312_9.htm EX-31.2 9312
4 EX-32.1 tcon-ex321_8.htm EX-32.1 5959
5 EX-32.2 tcon-ex322_6.htm EX-32.2 5705
  Complete submission text file 0001564590-22-028972.txt   5500551

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tcon-20220630.xsd EX-101.SCH 34053
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20220630_cal.xml EX-101.CAL 23723
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20220630_def.xml EX-101.DEF 97468
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20220630_lab.xml EX-101.LAB 249425
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20220630_pre.xml EX-101.PRE 182025
39 EXTRACTED XBRL INSTANCE DOCUMENT tcon-10q_20220630_htm.xml XML 850311
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 221152741
SIC: 2836 Biological Products, (No Diagnostic Substances)